Articles by Jon S. Kauffman, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jon S. Kauffman, PhD

Jon S. Kauffman, PhD

Manager

Jon S. Kauffman, PhD, is the manager of method development and validation at Lancaster Laboratories, Inc.

Articles
Identification and Risk-Assessment of Extractables and Leachables
February 1, 2006

Extractable and leachable issues should be resolved early in the drug manufacturing process. Open communication is imperative for a successful study.

Trends in Impurity Analyis: Determination of Extractables, Leachables, Residual Solvents, and Unknowns by Mass Spectrometry
August 1, 2003

Advances in mass spectrometry have made it a valuable tool for use in the quality-control laboratory.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here